非瘤学孤儿药物开发:生产力和成功概率
Samantha Parker1, Jida El Hajjar2, Anneliene H Jonker3
1International Rare Diseases Research Consortium, Paris, France; Italfarmaco SpA, Milan, Italy.
Drug discovery today
|December 4, 2025
概括
开发用于罕见疾病 (RDs) 的治疗方法仍然具有挑战性. 这项研究发现,生物制剂的批准率更高,而基因疗法和较小的赞助商在孤儿药物开发中面临障碍.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
- 药物开发 药物开发
背景情况:
- 超过6000种罕见疾病 (RDs) 影响全球3亿人,仅有有限的批准治疗方法.
- 孤儿药物名称 (ODD) 增加了,但治疗短缺仍然存在.
- 非瘤类孤儿药物面临着重大开发和批准挑战.
研究的目的:
- 分析2017年FDA和EMA指定的非瘤孤儿药物 (OD) 的7-8年结果.
- 确定影响孤儿药物开发成功的因素.
- 确定孤儿药物管道中的驱动因素和缺口.
主要方法:
- 2017年对292种非瘤孤儿药物名称的分析.
- 评估治疗方式,赞助商规模和资金.
- 开发阶段过渡成功率的评估.
主要成果:
- 与其他模式相比,生物药物表现出更高的批准率.
- 基因疗法表现出较低的阶段过渡成功率.
- 较小的公司和学术机构在开发中的成功率较低.
结论:
- 治疗方式,赞助商规模和资金显著影响孤儿药物开发的成功.
- 在将指定转化为批准的治疗方法方面存在差距,特别是在基因疗法和较小实体方面.
- 持续的,多利益相关者投资对于推进罕见疾病治疗至关重要.
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Prescription, Nonprescription and Orphan Drugs
1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Clinically Relevant Drug Product Specifications: Methods of Establishment
186
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
186
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
382
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
382


